1. Home
  2. /
  3. Capabilities
  4. /
  5. Phase II-IV Clinical Trial...

Phase II-IV Clinical Trial Management

Vast Therapeutic Expertise, Global Reach, and Seamless Execution

Lambda Therapeutic Research specializes in facilitating Phase II-IV studies for investigational new drugs (INDs), biologics, and medical devices. With over two decades of clinical operations experience, we offer a solid foundation and a comprehensive array of services to navigate the complexities of multi-centric clinical programs across various therapeutic areas. Our services encompass the entire clinical trial lifecycle, from initial study feasibility and pre-site qualification to study initiation, patient recruitment, site management, and thorough study monitoring, incorporating Central Monitoring, Remote Monitoring, and on-site monitoring. 

0
Late Phase Studies
0 +
Patients
0 +
Sites

Lambda & Novum has enrolled 85000+ patients in various therapeutic categories and conducted over 280 multicentric trials across different geographies with data submitted to all leading agencies including US FDA, EMEA, DCGI, ANVISA.

Therapeutic Expertise:

Lambda specializes in assisting small and mid-sized biotech Companies focused on groundbreaking science, particularly in intricate and challenging disease areas. Drawing upon extensive experience and proven expertise in these complex therapeutic domains, we bolster your team on the path to providing renewed hope for patients through the clinical journey. Our adept experts are enthusiastic about sharing their specialized knowledge and collaborating with you to drive forward your therapeutic pursuits.

No Data Found

Patient-Based PK Studies

Accelerating patient-based PK studies across therapeutic areas with a proven track record, overcoming challenges with precision and innovation.

Our Experience

No Data Found

Our Experience

No Data Found